Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mervyn Singer

Showing results (101-110 of 463) with videos related to

Pageof 47
Sort By:
Swiss Medical Weekly|November 14, 2008
Cellular processes in sepsisAlain Rudiger, Martin Stotz, Mervyn Singer
Intensive Care Medicine|May 2, 2024
Diagnosing sepsis: where we're at and where we're goingTobias Zimmermann, David Brealey, Mervyn Singer
Intensive Care Medicine|January 31, 2015
Understanding the benefits and harms of oxygen therapyPierre Asfar, Mervyn Singer, Peter Radermacher
Intensive Care Medicine|May 3, 2011
Temporal changes in tissue cardiorespiratory function during faecal peritonitisAlex Dyson, Alain Rudiger, Mervyn Singer
Intensive Care Medicine|November 12, 2024
Fludrocortisone with hydrocortisone in sepsis: new evidence in an ongoing debateOtavio Ranzani, Djillali Annane, Mervyn Singer
Critical Care Medicine|December 18, 2024
The Search for Sepsis Biomarkers: A Tale of Promises, Pitfalls, and PotentialTobias Zimmermann, David Brealey, Mervyn Singer
Critical Care Medicine|April 9, 2004
Severe bloodstream infections from the community: risk factors and outcomesAlberto Corona, Ferdinando Raimondi, Mervyn Singer
Lancet (London, England)|April 17, 2002
Terlipressin for norepinephrine-resistant septic shockAlastair O'Brien, Lucie Clapp, Mervyn Singer
Current Opinion in Critical Care|July 21, 2009
Is MOF an outcome parameter or a transient, adaptive state in critical illness?Nicolas Mongardon, Alex Dyson, Mervyn Singer
Intensive Care Medicine|July 29, 2015
Understanding the benefits and harms of oxygen therapy: response to comments by AkcaPierre Asfar, Mervyn Singer, Peter Radermacher
Pageof 47

Showing results (101-110 of 463) with videos related to

Sort By:
Pageof 47
Swiss Medical Weekly|November 14, 2008
Cellular processes in sepsisAlain Rudiger, Martin Stotz, Mervyn Singer
Intensive Care Medicine|May 2, 2024
Diagnosing sepsis: where we're at and where we're goingTobias Zimmermann, David Brealey, Mervyn Singer
Intensive Care Medicine|January 31, 2015
Understanding the benefits and harms of oxygen therapyPierre Asfar, Mervyn Singer, Peter Radermacher
Intensive Care Medicine|May 3, 2011
Temporal changes in tissue cardiorespiratory function during faecal peritonitisAlex Dyson, Alain Rudiger, Mervyn Singer
Intensive Care Medicine|November 12, 2024
Fludrocortisone with hydrocortisone in sepsis: new evidence in an ongoing debateOtavio Ranzani, Djillali Annane, Mervyn Singer
Critical Care Medicine|December 18, 2024
The Search for Sepsis Biomarkers: A Tale of Promises, Pitfalls, and PotentialTobias Zimmermann, David Brealey, Mervyn Singer
Critical Care Medicine|April 9, 2004
Severe bloodstream infections from the community: risk factors and outcomesAlberto Corona, Ferdinando Raimondi, Mervyn Singer
Lancet (London, England)|April 17, 2002
Terlipressin for norepinephrine-resistant septic shockAlastair O'Brien, Lucie Clapp, Mervyn Singer
Current Opinion in Critical Care|July 21, 2009
Is MOF an outcome parameter or a transient, adaptive state in critical illness?Nicolas Mongardon, Alex Dyson, Mervyn Singer
Intensive Care Medicine|July 29, 2015
Understanding the benefits and harms of oxygen therapy: response to comments by AkcaPierre Asfar, Mervyn Singer, Peter Radermacher
Pageof 47